Literature DB >> 19215610

Hypocholesterolemia in adult patients with thalassemia: a link with the severity of genotype in thalassemia intermedia patients.

Paolo Ricchi1, Massimiliano Ammirabile, Anna Spasiano, Silvia Costantini, Tiziana Di Matola, Patrizia Cinque, Leonilde Pagano, Luciano Prossomariti.   

Abstract

OBJECTIVES: Hypocholesterolemia has been previously described in patients affected by thalassemia. In this study we retrospectively evaluated the cholesterol level in two groups of patients affected by either thalassemia major (TM) or thalassemia intermedia (TI), with the aim of establishing factors correlated to hypocholesterolemia within both populations.
METHODS: All patients referring to our Unit of Thalassemia were considered. Observation time, defined as the interval between the first and last set of laboratory test, was 2 yr (January 2005-December 2006).
RESULTS: We found that patients with TI had significantly lower cholesterol and hemoglobin level as compared with TM patients. In addition there was no correlation between groups with identical genotype and cholesterol levels in both populations. However, within the TI group, lower values of cholesterol were found in patients with more severe genotype and lower body mass index.
CONCLUSIONS: Our data support the hypothesis that, independently from single genotype involved, the reduced level of cholesterol in patients with TI are sustained by active erythropoiesis which increases cholesterol requirement.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19215610     DOI: 10.1111/j.1600-0609.2008.01195.x

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


  10 in total

1.  Extramedullary haematopoiesis correlates with genotype and absence of cardiac iron overload in polytransfused adults with thalassaemia.

Authors:  Paolo Ricchi; Massimiliano Ammirabile; Anna Spasiano; Silvia Costantini; Tiziana Di Matola; Alessia Pepe; Patrizia Cinque; Leonilde Pagano; Maddalena Casale; Aldo Filosa; Luciano Prossomariti
Journal:  Blood Transfus       Date:  2013-10-03       Impact factor: 3.443

2.  Soluble form of transferrin receptor as a biomarker of overall morbidity in patients with non-transfusion-dependent thalassaemia: a cross-sectional study.

Authors:  Paolo Ricchi; Massimiliano Ammirabile; Silvia Costantini; Anna Spasiano; Tiziana Di Matola; Roberto Verna; Alessia Pepe; Patrizia Cinque; Caterina Saporito; Aldo Filosa; Leonilde Pagano
Journal:  Blood Transfus       Date:  2016-05-03       Impact factor: 3.443

3.  Depleted nitric oxide and prostaglandin E2 levels are correlated with endothelial dysfunction in β-thalassemia/HbE patients.

Authors:  Sudarat Satitthummanid; Noppacharn Uaprasert; Smonporn Boonyaratavej Songmuang; Ponlapat Rojnuckarin; Piyaratana Tosukhowong; Pranee Sutcharitchan; Suphot Srimahachota
Journal:  Int J Hematol       Date:  2017-05-04       Impact factor: 2.490

4.  Plasma lipids and lipoproteins in children and young adults with major β-thalassemia from western Iran: influence of genotype.

Authors:  Hamid Madani; Zohreh Rahimi; Mohammad Manavi-Shad; Hadi Mozafari; Reza Akramipour; Asad Vaisi-Raygani; Mansour Rezaei; Shohreh Malek-Khosravi; Ebrahim Shakiba; Abbas Parsian
Journal:  Mol Biol Rep       Date:  2010-11-18       Impact factor: 2.316

Review 5.  Mechanisms and genetic determinants regulating sterol absorption, circulating LDL levels, and sterol elimination: implications for classification and disease risk.

Authors:  Sebastiano Calandra; Patrizia Tarugi; Helen E Speedy; Andrew F Dean; Stefano Bertolini; Carol C Shoulders
Journal:  J Lipid Res       Date:  2011-08-23       Impact factor: 5.922

6.  Metabolic pathways related to oxidative stress in patients with hemoglobin h disease and iron overload.

Authors:  Shyh-Shin Chiou; Chao-Jung Tsao; Shih-Meng Tsai; Ye-Ru Wu; Yu-Mei Liao; Pei-Chin Lin; Li-Yu Tsai
Journal:  J Clin Lab Anal       Date:  2014-02-27       Impact factor: 2.352

7.  Vasculo-toxic and pro-inflammatory action of unbound haemoglobin, haem and iron in transfusion-dependent patients with haemolytic anaemias.

Authors:  Francesca Vinchi; Richard Sparla; Sara T Passos; Richa Sharma; S Zebulon Vance; Hala S Zreid; Hesham Juaidi; Deepa Manwani; Karina Yazdanbakhsh; Vijay Nandi; André M N Silva; Anand R Agarvas; Eitan Fibach; John D Belcher; Gregory M Vercellotti; Husam Ghoti; Martina U Muckenthaler
Journal:  Br J Haematol       Date:  2021-03-15       Impact factor: 6.998

8.  Serum lipid profiles in patients with beta-thalassemia major and intermedia in southern Iran.

Authors:  Sezaneh Haghpanah; Maryam Davani; Behrang Samadi; Afsaneh Ashrafi; Mehran Karimi
Journal:  J Res Med Sci       Date:  2010-05       Impact factor: 1.852

9.  Premature atherosclerosis in children with beta-thalassemia major: New diagnostic marker.

Authors:  Laila M Sherief; Osama Dawood; Adel Ali; Hanan S Sherbiny; Naglaa M Kamal; Mohamed Elshanshory; Osama Abd Alazez; Mohamed Abd Alhady; Mohamed Nour; Wesam A Mokhtar
Journal:  BMC Pediatr       Date:  2017-03-09       Impact factor: 2.125

Review 10.  Non-Transferrin-Bound Iron in the Spotlight: Novel Mechanistic Insights into the Vasculotoxic and Atherosclerotic Effect of Iron.

Authors:  Francesca Vinchi
Journal:  Antioxid Redox Signal       Date:  2021-03-22       Impact factor: 8.401

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.